Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin

Journal of Interferon and Cytokine Research

Volumn 28, Issue 10, 2008, Pages 603-609

  Malaguarnera, Mariano ^a,c   Vicari, Enzo ^b   Calogero, Aldo ^b   Cammalleri, Lisa ^a   Fazio, Ignazio Di ^a   Gargante, Maria Pia ^a   Pennisi, Giovanni ^a   Risino, Corrado ^a   Ranno, Salvatore ^a   Rampello, Liborio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON A; RIBAVIRIN;

ADULT; ANOREXIA; ANXIETY; ARTICLE; DEPRESSION; DRUG INDUCED HEADACHE; FATIGUE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRRITABILITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MUSCULOSKELETAL PAIN; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PENIS ERECTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; ERECTILE DYSFUNCTION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RIBAVIRIN;

HEPATITIS C VIRUS;

EID: 54249154652     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0021     Document Type: Article

References (23)

1. Alter MJ. 1999. Hepatitis C Virus infection in the United States. J Hepatol 31(1):88-91.
2. Barreca T, Picciotto A, Franceschini R, Varagona G, Garibaldi A, Valle F, Cataldi A, D'Agostino S, Rolandi E. 1993a. Sex hormones and sex hormone-binding globulin in males with chronic viral hepatitis during recombinant interferon-alpha 2b therapy. J Interferon Res 13:209-211.
3. Barreca T, Picciotto A, Franceschini R, Varagona G, Corsini G, Valle F, Cataldi A, Molinari E, Garibaldi A, Rolandi E. 1993b. Long term therapy with recombinant interferon alpha 2 b in patients with chronic hepatitis C: effects on thyroid function and autoantibodies. J Biol Regul Homeost Agents 7:58-62.
4. Black PH. 2002. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16:622-653.
5. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR, HALT-C Trial Group. 2007. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol 46:420-431.
6. Corssmit EP, Endert E, Sauerwein HP, Romijn JA. 2000. Acute effects of interferon-alpha administration on testosterone concentrations in healthy men. Eur J Endocrinol 143:371-374.
7. Foster GR. 1999. Hepatitis C virus infection: quality of life and side effects of treatment. J Hepatol 31:250-254.
8. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. 1998. Oral sildenafil in the treatment of erectile dysfunction. New Engl J Med 338:1397-1405.
9. Herrine SK, Brown RS, Bernstein DE, Ondovik MS, Lentz E, Te H. 2005. Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral break-through on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. Dig Dis Sci 50:719-726.
10. Hilsabeck RC, Perry W, Hassanein TI. 2002. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 35:440-446.
11. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
12. Kraus MR, Schäfer A, Bentink T, Scheurlen M, Weissbrich B, Al-Taie O, Seufert J. 2005. Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? J Endocrinol 185:345-352.
13. Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Ferlito L, Rampello L. 1998. Interferon alpha induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 37:93-97.
14. Malaguarnera M, Laurino A, Di Fazio I, Pistone G, Castorina M, Guccione N, Rampello L. 2001. Neuropsychiatric effects and type of IFN alpha in chronic hepatitis C. J Interferon Cytokine Res 21:273-278.
15. Nguyen HV, Mollison LC, Taylor TW, Chubb SA, Yeap BB. 2006. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy. Intern Med J 36:362-366.
16. Nurnberg HG, Hensley PL. 2003. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance. CNS Spectr 8:194-202.
17. Piazza M, Tosone G, Borgia G, Orlando R, Fenzi G, Vitale M, Bloise A, Mariano A, Macchia V. 1997. Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. J Interferon Cytokine Res 17:525-529.
18. Poynard T, Moussalli J, Ratziu V, Thevenot T, Regimbeau C, Opolon P, Horsmans Y, Brenard R, Closon M, Fevery J, Hautekeete M. 1998. Is antiviral treatment (IFN Alpha and/or Ribavirin) justified in cirrhosis related to hepatitis C virus? Societe Royale Belge De Gastro-Enterologie. Acta Gastroenterol Belg 61:431-437.
19. Rosen RC. 2001a. Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am 28:269-278.
20. Rosen RC. 2001b. Measurement of male and female sexual dysfunction. Curr Psychiatry Rep 3:182-187.
21. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Bréchot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzaki A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Leile PN, Maertens G, McHomish F, Miyamura T, Mizokami M, Nomoyo A, Prince AM, Reesenki HW, Rice C, Roggendorf M, Schaalm SW, Shikata T, Shimothohono K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
22. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102.
23. Ware JE, Bayliss MS, Mannocchia M, Davis GL. 1999. Health-Related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 30:550-555.